Cargando…

Mechanistic insights into the aggregation pathway of the patient-derived immunoglobulin light chain variable domain protein FOR005

Systemic antibody light chain (AL) amyloidosis is characterized by deposition of amyloid fibrils. Prior to fibril formation, soluble oligomeric AL protein has a direct cytotoxic effect on cardiomyocytes. We focus on the patient derived λ-III AL variable domain FOR005 which is mutated at five positio...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradhan, Tejaswini, Sarkar, Riddhiman, Meighen-Berger, Kevin M., Feige, Matthias J., Zacharias, Martin, Reif, Bernd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290123/
https://www.ncbi.nlm.nih.gov/pubmed/37353525
http://dx.doi.org/10.1038/s41467-023-39280-0
_version_ 1785062424653594624
author Pradhan, Tejaswini
Sarkar, Riddhiman
Meighen-Berger, Kevin M.
Feige, Matthias J.
Zacharias, Martin
Reif, Bernd
author_facet Pradhan, Tejaswini
Sarkar, Riddhiman
Meighen-Berger, Kevin M.
Feige, Matthias J.
Zacharias, Martin
Reif, Bernd
author_sort Pradhan, Tejaswini
collection PubMed
description Systemic antibody light chain (AL) amyloidosis is characterized by deposition of amyloid fibrils. Prior to fibril formation, soluble oligomeric AL protein has a direct cytotoxic effect on cardiomyocytes. We focus on the patient derived λ-III AL variable domain FOR005 which is mutated at five positions with respect to the closest germline protein. Using solution-state NMR spectroscopy, we follow the individual steps involved in protein misfolding from the native to the amyloid fibril state. Unfavorable mutations in the complementary determining regions introduce a strain in the native protein structure which yields partial unfolding. Driven by electrostatic interactions, the protein converts into a high molecular weight, oligomeric, molten globule. The high local concentration of aggregation prone regions in the oligomer finally catalyzes the conversion into fibrils. The topology is determined by balanced electrostatic interactions in the fibril core implying a 180° rotational switch of the beta-sheets around the conserved disulfide bond.
format Online
Article
Text
id pubmed-10290123
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-102901232023-06-25 Mechanistic insights into the aggregation pathway of the patient-derived immunoglobulin light chain variable domain protein FOR005 Pradhan, Tejaswini Sarkar, Riddhiman Meighen-Berger, Kevin M. Feige, Matthias J. Zacharias, Martin Reif, Bernd Nat Commun Article Systemic antibody light chain (AL) amyloidosis is characterized by deposition of amyloid fibrils. Prior to fibril formation, soluble oligomeric AL protein has a direct cytotoxic effect on cardiomyocytes. We focus on the patient derived λ-III AL variable domain FOR005 which is mutated at five positions with respect to the closest germline protein. Using solution-state NMR spectroscopy, we follow the individual steps involved in protein misfolding from the native to the amyloid fibril state. Unfavorable mutations in the complementary determining regions introduce a strain in the native protein structure which yields partial unfolding. Driven by electrostatic interactions, the protein converts into a high molecular weight, oligomeric, molten globule. The high local concentration of aggregation prone regions in the oligomer finally catalyzes the conversion into fibrils. The topology is determined by balanced electrostatic interactions in the fibril core implying a 180° rotational switch of the beta-sheets around the conserved disulfide bond. Nature Publishing Group UK 2023-06-23 /pmc/articles/PMC10290123/ /pubmed/37353525 http://dx.doi.org/10.1038/s41467-023-39280-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Pradhan, Tejaswini
Sarkar, Riddhiman
Meighen-Berger, Kevin M.
Feige, Matthias J.
Zacharias, Martin
Reif, Bernd
Mechanistic insights into the aggregation pathway of the patient-derived immunoglobulin light chain variable domain protein FOR005
title Mechanistic insights into the aggregation pathway of the patient-derived immunoglobulin light chain variable domain protein FOR005
title_full Mechanistic insights into the aggregation pathway of the patient-derived immunoglobulin light chain variable domain protein FOR005
title_fullStr Mechanistic insights into the aggregation pathway of the patient-derived immunoglobulin light chain variable domain protein FOR005
title_full_unstemmed Mechanistic insights into the aggregation pathway of the patient-derived immunoglobulin light chain variable domain protein FOR005
title_short Mechanistic insights into the aggregation pathway of the patient-derived immunoglobulin light chain variable domain protein FOR005
title_sort mechanistic insights into the aggregation pathway of the patient-derived immunoglobulin light chain variable domain protein for005
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290123/
https://www.ncbi.nlm.nih.gov/pubmed/37353525
http://dx.doi.org/10.1038/s41467-023-39280-0
work_keys_str_mv AT pradhantejaswini mechanisticinsightsintotheaggregationpathwayofthepatientderivedimmunoglobulinlightchainvariabledomainproteinfor005
AT sarkarriddhiman mechanisticinsightsintotheaggregationpathwayofthepatientderivedimmunoglobulinlightchainvariabledomainproteinfor005
AT meighenbergerkevinm mechanisticinsightsintotheaggregationpathwayofthepatientderivedimmunoglobulinlightchainvariabledomainproteinfor005
AT feigematthiasj mechanisticinsightsintotheaggregationpathwayofthepatientderivedimmunoglobulinlightchainvariabledomainproteinfor005
AT zachariasmartin mechanisticinsightsintotheaggregationpathwayofthepatientderivedimmunoglobulinlightchainvariabledomainproteinfor005
AT reifbernd mechanisticinsightsintotheaggregationpathwayofthepatientderivedimmunoglobulinlightchainvariabledomainproteinfor005